• Citer

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.

par Rizzoli, René;Body, Jean-Jacques ;De Censi, A;Reginster, Jean-Yves;Piscitelli, P;Brandi, M L;European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO),
Référence Osteoporosis international, 23, 11, page (2567-2576)
Publication Publié, 2012-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.
Auteur:	Rizzoli, René; Body, Jean-Jacques; De Censi, A; Reginster, Jean-Yves; Piscitelli, P; Brandi, M L; European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO),
Informations sur la publication:	Osteoporosis international, 23, 11, page (2567-2576)
Statut de publication:	Publié, 2012-11
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Aromatase inhibitors
	Bisphosphonates
	Bone loss
	Breast cancer
	Fracture risk
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0937-941X
	info:doi/10.1007/s00198-011-1870-0
	info:scp/84868193373
	info:pmid/22270857